OMNIPAQUE (GE Healthcare Inc.)
Welcome to the PulseAid listing for the OMNIPAQUE drug offered from GE Healthcare Inc.. This Radiographic Contrast Agent [EPC],X-Ray Contrast Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | GE Healthcare Inc. |
| NON-PROPRIETARY NAME: | Iohexol |
| SUBSTANCE NAME: | IOHEXOL |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Radiographic Contrast Agent [EPC],X-Ray Contrast Activity [MoA] |
| ROUTE: | INTRATHECAL; INTRAVASCULAR; INTRAVENOUS; ORAL |
| DOSAGE FORM: | INJECTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2006-09-21 |
| END MARKETING DATE: | 0000-00-00 |
OMNIPAQUE HUMAN PRESCRIPTION DRUG Details:
| Item Description | OMNIPAQUE from GE Healthcare Inc. |
| LABELER NAME: | GE Healthcare Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 647(mg/mL) |
| START MARKETING DATE: | 2006-09-21 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0407-1413_8189551d-c91e-4031-88d9-3dd0f2ab8c97 |
| PRODUCT NDC: | 0407-1413 |
| APPLICATION NUMBER: | NDA018956 |
Other IOHEXOL Pharmaceutical Manufacturers / Labelers:
